Who owns Sellas Life Sciences Group I?

Tip: Access positions for across all investors

Analyze quarterly positions in Sellas Life Sciences Group I with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Sellas Life Sciences Group I stock

Who bought or sold Sellas Life Sciences Group I this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Alyeska Investment Group 1.3M $1.4M -22% Dec 2023
 View chart
Vanguard Group 1.1M $1.2M 11% Dec 2023
 View chart
Citadel Advisors 281k $298k 3% Dec 2023
 View chart
Opus Capital Group 135k $143k 291% Dec 2023
 View chart
Bank of New York Mellon 85k $90k 315% Dec 2023
 View chart
Virtu Financial 60k $64k 216% Dec 2023
 View chart
Wells Fargo & Company 16k $17k 0% Dec 2023
 View chart
Charles Schwab Investment Management 16k $17k 0% Dec 2023
 View chart
Two Sigma Securities 15k $16k 100% Dec 2023
 View chart
Commonwealth Equity Services 12k $13k 0% Dec 2023
 View chart
Millennium Management 11k $12k 100% Dec 2023
 View chart
Brooklyn FI 11k $11k 100% Mar 2024
 View chart
Nemes Rush Group 10k $11k 0% Dec 2023
 View chart
Jpmorgan Chase & Co 9.8k $10k 143% Dec 2023
 View chart
Advisor Group Holdings 1.7k $1.8k -50% Dec 2023
 View chart
Royal Bank of Canada 358.00 $0 79% Dec 2023
 View chart
Hanson McClain Advisors 150.00 $159.000000 0% Dec 2023
 View chart
Bank of America Corporation 42.00 $43.999200 100% Dec 2023
 View chart
JJJ Advisors 11.00 $11.999900 0% Mar 2024
 View chart
Parkside Financial Bank & Trust 2.00 $3.000000 0% Dec 2023
 View chart

Who sold out of Sellas Life Sciences Group I?

Fund or Company Name Date Sold Shares Held Valued At
Jane Street Sep 2023 11k $18k
UBS Group Sep 2023 26.00 $42.998800